With 3.1 percent of the 2022 budget, $1.3 billion, Nigeria could acquire complete doses of the RTS, S/AS01 malaria vaccine for the current generation of children under five, ending the scourge of a disease that kills 95,000 children yearly.
This is if the government foots 100 percent of the finan
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
